RK&O is pleased to announce that the 2019 edition of Hedge Fund Equity Investing: U.S. Legal Issues, written by RK&O partner Scott C. Budlong, has been published by Bloomberg Law® as part of its Securities Practice Portfolio Series. This newly updated publication focuses on issues related to federal securities law that may apply to hedge funds when buying, holding and selling U.S. equity securities.
The publication systematically addresses a variety of recurring issues faced by in-house counsel at hedge fund managers. Topics covered include: SEC reporting (Section 13 and Section 16); liquidity issues (Rule 144 public resales, various private resales, short selling and reorg equity); other securities regulatory issues (avoiding problems under the SEC’s proxy rules, tender offer rules and anti-market manipulation rules); and legal and issuer-specific limits on equity ownership (the HSR Act, Delaware’s business combination statute and shareholder rights plans).
The updates to the 2019 edition include new content on Form 13F amendments and confidential treatment requests; the treatment of warrants and similar securities issued under Section 1145 of the U.S. Bankruptcy Code; the SEC's new focus on "short-and-distort" schemes as a form of illegal market manipulation; and the evolution of poison pill drafting that attempts to capture parties "acting in concert".
Bloomberg Law® portfolios are written by expert practitioners and feature deep-dive analysis and practice tools, such as checklists, charts, forms and other supporting material, on a wide range of key legal topics. These publications are available online to Bloomberg Law® subscribers.
To request a hard copy of the 2019 edition of Hedge Fund Equity Investing: U.S. Legal Issues, please email email@example.com.